Use of 2,4-pyrimidinediamine compounds in the preparation of medicaments for treating autoimmune diseases

摘要

Disclosed herein is a use of 2,4-pyrimidinediamine compounds of formula (I) in the preparation of a medicament for the treatment of an autoimmune diseases selected from autoimmune disease is selected from the group consisting of Hashimoto's thyroiditis, autoimmune hemolytic anemia, autoimmune atrophic gastritis of pernicious anemia, autoimmune encephalomyelitis, autoimmune orchitis, Goodpasture's disease, autoimmune thrombocytopenia, sympathetic ophthalmia, myasthenia gravis, Graves' disease, primary biliary cirrhosis, chronic aggressive hepatitis and membranous glomerulopathy, wherein the variables shown in formula (I) are as defined in the specification.